Lecture report by the “StudyWorks®” Product Development Department Manager released – The challenge of developing a DCT platform in collaboration with clinical trial sites –
Press
Notice of New Year’s holiday closure and thanks for the year
Thank you for using Buzzreach’s services.
We apologize for any inconvenience, but our company will be closed during the following period for the New Year holidays.
[Year-end and New Year holiday period]
Saturday, December 27, 2025 – Sunday, January 4, 2026
Normal business hours will resume on Monday, January 5, 2026.
We will respond to inquiries received during the closure period in the order they are received once we resume business.
We apologize for any inconvenience this may cause, and we appreciate your understanding.
In the event of an emergency, please contact the person in charge.
We would like to express our sincere gratitude for your continued use of our various services and for your generous support and cooperation this year.
All of our employees are extremely grateful to have been able to work with you to improve the environment for new drug development and clinical trials in Japan.
Next year, we will continue to leverage the power of technology to promote the efficiency of clinical trials and research, and strive even harder to bring new treatment options to patients more quickly.
We look forward to your continued support of Buzzreach Inc.
I hope you all have a happy new year.
Related Articles
-
-
Published an article titled “Future Outlook for Digitalization of Clinical Trial Management: Considering the Benefits of Work Reduction Through System Use”
-
[Webinar] Eliminate the risk of not achieving your goals! “Regional Collaboration DCT” strategy to accelerate case registration
-
We will be exhibiting a corporate booth at the 57th Annual Meeting of the Japanese Society of Pediatric Respiratory Medicine.
-
Guidance and request for cooperation regarding the handling of clinical trial information when using the clinical trial support system “StudyWorks”
-
Published an article on the application of DCT (Decentralized Clinical Trials) in Japan and the future of DX in the clinical trial industry
-
Representative Ikawa will be speaking at the 22nd DIA Japan Annual Meeting 2025, and the company will have a booth.
-
A paper by our representative, Inogawa, was published in Volume 42, Issue 3 of Neurotherapeutics, the journal of the Japanese Society of Neurotherapeutics.
-
[Webinar] DCT model created by medical institutions in collaboration with partner sites
-
We will be co-hosting a seminar and exhibiting a corporate booth at the ARO Council’s 12th Academic Conference in Chiba.